Olivier Loeillot, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 5,877 shares at $165.90 ($986K) on 2026-09-04, disclosed to the SEC on 2026-09-08.
Scheduled sale ($986k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.61 | 2,842 | $482K | 48.9% |
| 2 | $165.90 | 3,035 | $504K | 51.1% |
| Total | $167.69 avg | 5,877 | $986K | 100% |
| Filing → |
| RGEN | SELL | 2026-09-22 | $977K | — | Filing → |
| RGEN | SELL | 2026-08-21 | $977K | — | Filing → |
| RGEN | SELL | 2026-04-22 | $536K | — | Filing → |